Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy

Keyphrases

• Distant Metastasis 100%
• Improved Outcomes 100%
• Residual Disease 100%
• Neoadjuvant Chemotherapy 100%
• Aspirin Use 100%
• Disease-free Survival 66%
• Clinical High Risk 66%
• Breast Cancer Patients 66%
• Multivariable 66%
• Breast Cancer 33%
• Breast Cancer Risk 33%
• Pathologic 33%
• Triple Negative 33%
• Prospective Clinical Trial 33%
• Patients at Risk 33%
• 5-year Survival 33%
• Complete Response 33%
• Non-responders 33%
• Aspirin 33%
• Worse Outcome 33%
• Survival Outcomes 33%
• Kaplan-Meier Analysis 33%
• Stage II-III 33%
• Hormone Receptor-positive 33%
• Nodal Disease 33%
• Ultra-high Risk 33%
• Pathologic Parameters 33%
• Cox Proportional Hazards Regression Analysis 33%
• HER2+ 33%
• IRB Protocol 33%

Medicine and Dentistry

• Distant Metastasis 100%
• Acetylsalicylic Acid 100%
• Neoadjuvant Chemotherapy 100%
• Minimal Residual Disease 100%
• Breast Cancer 25%
• Disease Free Survival 25%
• Disease 8%
• Clinical Trial 8%
• Proportional Hazards Model 8%
• Kaplan Meier Method 8%
• Hormone Receptor 8%
• Clinical Stage 8%

Immunology and Microbiology

• Disease Free Survival 100%